Two Sigma Investments
XBIO icon

Two Sigma Investments’s Xenetic Biosciences XBIO Stock Holding History

Two Sigma Investments’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,307
Closed -$334K – 4962
2021
Q3 		$334K Buy
+16,307
New +$444K ﹤0.01% 3578

Other funds holding XBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Two Sigma Investments's XBIO Position: Q4 2021 in Review

Two Sigma Investments sold out of Xenetic Biosciences (XBIO) in Q4 2021, closing a stake of 16,307 shares — an estimated $334K sold.

Two Sigma Investments first reported a position in XBIO in Q3 2021 and held it in 1 quarter. The position peaked at $334K in Q3 2021. 22 funds tracked by Wall St. Rank hold XBIO as of Q4 2021.

  • Two Sigma Investments reported no remaining Xenetic Biosciences position as of Q4 2021 after selling out during the quarter.
  • Two Sigma Investments sold 16,307 Xenetic Biosciences shares in Q4 2021, an estimated $334K.
  • Two Sigma Investments first reported a position in Xenetic Biosciences in Q3 2021 and held it in 1 quarter.
  • Two Sigma Investments's Xenetic Biosciences position peaked at $334K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q4 2021.

Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.